• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-

Return to search Page to restart searchReturn to Orphan Designation Search PageReturn to Search Page
 
Generic Name:treprostinil
Trade Name:Remodulin
Date Designated: 06-04-1997
Orphan Designation:Treatment of pulmonary arterial hypertension.
Orphan Designation Status: Designated/Approved
FDA Orphan Approval Status:Approved for Orphan Indication
Approved Labeled Indication:Treatment of pulmonary arterial hypertension. 
Marketing Approval Date: 05-21-2002
Exclusivity End Date: 05-21-2009
United Therapeutics Corp.
55 T.W. Alexander Dr.
Research Triangle Park, NC 27709

The sponsor address listed is the last reported by the sponsor to OOPD.

-
-